Amarantus BioScience Holdings Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,032.60
214.00
176.00
49.20
47.20
0.80
Total Accounts Receivable
-
-
-
639.10
598.70
34.20
Other Current Assets
106.00
198.00
567.00
1,628.30
792.60
717.60
Total Current Assets
1,138.60
412.00
743.00
2,316.60
1,438.50
752.60
Net Property, Plant & Equipment
-
145.00
115.00
17.20
-
-
Total Investments and Advances
-
204.00
-
8,800.00
8,800.00
2,726.70
Intangible Assets
611.10
1,497.00
10,828.00
-
-
1.30
Other Assets
109.20
-
85.00
-
-
-
Total Assets
1,858.90
2,258.00
11,771.00
11,133.90
10,238.50
3,480.50
ST Debt & Current Portion LT Debt
7,137.60
222.00
3,141.00
11,449.10
10,673.80
Accounts Payable
971.20
-
-
15,265.20
17,581.40
Other Current Liabilities
430.40
6,107.00
13,051.00
-
-
Total Current Liabilities
8,539.20
6,329.00
16,192.00
26,714.30
28,255.20
Deferred Taxes
-
-
1,113.00
-
-
Total Liabilities
8,539.20
6,329.00
17,305.00
26,714.30
28,255.20
Common Equity (Total)
7,519.90
9,291.00
17,453.00
15,580.40
18,016.70
Total Shareholders' Equity
6,680.30
4,071.00
5,534.00
15,580.40
18,016.70
Total Equity
6,680.30
4,071.00
5,534.00
15,580.40
18,016.70
Liabilities & Shareholders' Equity
1,858.90
2,258.00
11,771.00
11,133.90
10,238.50
Preferred Stock (Carrying Value)
839.60
5,220.00
11,919.00
-
-
About Amarantus BioScience Holdings
View Profile
